Micro-X Limited (ASX:MX1)
0.0510
0.00 (0.00%)
Apr 7, 2026, 3:33 PM AEST
Micro-X Market Cap
Micro-X has a market cap or net worth of 37.03 million as of April 7, 2026. Its market cap has decreased by -13.07% in one year.
Market Cap
37.03M
Enterprise Value
34.96M
Revenue
16.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since December 22, 2015, Micro-X's market cap has decreased from 71.65M to 37.03M, a decrease of -48.32%. That is a compound annual growth rate of -6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 37.03M | -51.28% |
| Dec 31, 2025 | 76.00M | 55.15% |
| Dec 31, 2024 | 48.98M | -9.95% |
| Dec 29, 2023 | 54.40M | -18.58% |
| Dec 30, 2022 | 66.81M | -43.06% |
| Dec 31, 2021 | 117.33M | -8.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 75.96M |
| Compumedics | 54.93M |
| HeraMED | 54.28M |
| CleanSpace Holdings | 37.09M |
| Nova Eye Medical | 35.61M |
| ImpediMed | 31.60M |
| Atomo Diagnostics | 25.93M |
| Control Bionics | 24.72M |